The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer

DSC3 expression is regulated by p53 and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer

(2011) T Cui et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Desmosomes

(2011) Adi D. Dubash et al.   CURRENT BIOLOGY

Utility of 10 Immunohistochemical Markers Including Novel Markers (Desmocollin-3, Glypican 3, S100A2, S100A7, and Sox-2) for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung

(2011) Koji Tsuta et al.   Journal of Thoracic Oncology

Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling

(2011) Keli Kolegraff et al.   MOLECULAR BIOLOGY OF THE CELL

Loss of desmocollin 3 in skin tumor development and progression

(2011) Jiangli Chen et al.   MOLECULAR CARCINOGENESIS

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

(2009) Valentina Monica et al.   MODERN PATHOLOGY

Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients

(2008) Michelle P. Wong et al.   PATHOLOGY